Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 8Breast Neoplasms 8Neoplasms 7Depression 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Head and Neck Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Anxiety Disorders 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Prostatic Hyperplasia 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Fatigue 2

Interventions

Gemcitabine 56pembrolizumab 51Cisplatin 43Magnetic Resonance Spectroscopy 27enfortumab vedotin 23Specimen Handling 22Nivolumab 22Cystectomy 18durvalumab 16Carboplatin 16avelumab 14Mitomycin 14atezolizumab 13Docetaxel 13Cystoscopy 12Fluorouracil 11Radiation 9Transurethral Resection of Bladder 8Radiotherapy 8Ipilimumab 8sacituzumab govitecan 7Standard of Care 7Radiosurgery 7Paclitaxel 7Immunoglobulin G 7Disulfides 7erdafitinib 6cemiplimab 6Surveys and Questionnaires 6Surgical Procedures, Operative 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Therapeutics × 1 year × Clear all
NCT07555756 2026-04-29

An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models

First Affiliated Hospital of Guangxi Medical University

Phase NA Not yet recruiting
1,080 enrolled
Genitourinary

Urinary Bladder Neoplasms, Kidney Calculi, Prostatic Hyperplasia

NCT07395037 2026-02-09

WASHOUT

British Urology Researchers in Surgical Training

Recruiting
1,050 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Kidney Neoplasms, Urologic Diseases

NCT07307456 2025-12-29

Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Changhai Hospital

Phase 2 Recruiting
31 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡